» Articles » PMID: 36003962

Iron Deposition in the Precuneus is Correlated with Mild Cognitive Impairment in Patients with Cerebral Microbleeds: A Quantitative Susceptibility Mapping Study

Overview
Journal Front Neurosci
Date 2022 Aug 25
PMID 36003962
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this study was to define whether mild cognitive impairment (MCI) is associated with iron deposition in rich-club nodes distant from cerebral microbleeds (CMBs) in patients with cerebral small vessel disease (CSVD).

Methods: A total of 64 participants underwent magnetic resonance imaging (MRI) scanning and were separated into three groups, namely, CMB(+), CMB(-), and healthy controls (HCs). We compared their characteristics and susceptibility values of rich-club nodes [e.g., superior frontal gyrus (SFG), precuneus, superior occipital gyrus (SOG), thalamus, and putamen]. We then divided the CMB(+) and CMB(-) groups into subgroups of patients with or without MCI. Then, we analyzed the relationship between iron deposition and MCI by comparing the susceptibility values of rich-club nodes. We assessed cognitive functions using the Montreal Cognitive Assessment (MoCA) and quantified iron content using quantitative susceptibility mapping (QSM).

Results: In the putamen, the CMB(+) and CMB(-) groups had significantly different susceptibility values. Compared with the HCs, the CMB(+) and CMB(-) groups had significantly different susceptibility values for the SFG and SOG. In addition, we found significant differences in the putamen susceptibility values of the CMB(+)MCI(+) group and the two CMB(-) groups. The CMB(+)MCI(+) and CMB(+)MCI(-) groups had significantly different precuneus susceptibility values. The binary logistic regression analysis revealed that only higher susceptibility values of precuneus were associated with a cognitive decline in patients with CMBs, and it indicated statistical significance.

Conclusion: Iron deposition in the precuneus is an independent risk factor for MCI in patients with CMBs. CMBs might influence iron content in remote rich-club nodes and be relevant to MCI.

Citing Articles

Iron accumulation/overload and Alzheimer's disease risk factors in the precuneus region: A comprehensive narrative review.

Mohammadi S, Ghaderi S, Fatehi F Aging Med (Milton). 2024; 7(5):649-667.

PMID: 39507230 PMC: 11535174. DOI: 10.1002/agm2.12363.


Deeper insight into ferroptosis: association with Alzheimer's, Parkinson's disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis.

Yadav V, Choudhary N, Gacem A, Verma R, Hasan M, Imam M Redox Rep. 2023; 28(1):2269331.

PMID: 38010378 PMC: 11001282. DOI: 10.1080/13510002.2023.2269331.


Multimodal comparisons of QSM and PET in neurodegeneration and aging.

Cogswell P, Fan A Neuroimage. 2023; 273:120068.

PMID: 37003447 PMC: 10947478. DOI: 10.1016/j.neuroimage.2023.120068.

References
1.
Wei H, Dibb R, Zhou Y, Sun Y, Xu J, Wang N . Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range. NMR Biomed. 2015; 28(10):1294-303. PMC: 4572914. DOI: 10.1002/nbm.3383. View

2.
Wardlaw J, Smith E, Biessels G, Cordonnier C, Fazekas F, Frayne R . Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013; 12(8):822-38. PMC: 3714437. DOI: 10.1016/S1474-4422(13)70124-8. View

3.
Valdes Hernandez M, Allerhand M, Glatz A, Clayson L, Munoz Maniega S, Gow A . Do white matter hyperintensities mediate the association between brain iron deposition and cognitive abilities in older people?. Eur J Neurol. 2016; 23(7):1202-9. PMC: 4950475. DOI: 10.1111/ene.13006. View

4.
Ding J, Sigurdsson S, Jonsson P, Eiriksdottir G, Meirelles O, Kjartansson O . Space and location of cerebral microbleeds, cognitive decline, and dementia in the community. Neurology. 2017; 88(22):2089-2097. PMC: 5447401. DOI: 10.1212/WNL.0000000000003983. View

5.
Schroder N, Figueiredo L, Martins de Lima M . Role of brain iron accumulation in cognitive dysfunction: evidence from animal models and human studies. J Alzheimers Dis. 2012; 34(4):797-812. DOI: 10.3233/JAD-121996. View